Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The Head, The Heart and The Gut
View:
Post by N0taP00p on Jan 31, 2023 10:12am

The Head, The Heart and The Gut

My head says: This is a Canadian penny stock that's been languishing in the trenches for a dozen plus years.  No one knows about this company. There is a lack of management trust. An inability to raise money with decent terms and with the backing of its science and clinical data.  They will delay again and make excuses. The longs will explain it away. Groundhog Day every day. 

My Heart says: Breakthrough drugs require a lot of toil, trial and errors. If this were in the US, might have been a different story in terms of financing, publicity , opportunities for collaboration, etc. It's going to break to the upside very soon. Bladders Forever, with Rutherrin instead of Vibranium. Waiting to be discovered by the world. 

My Gut?  My gut says, if they miss this Q1 deadline for whatever reason, I must  say Goodbye Forever to 50 percent of my shares and defer to the head, going forward.
Comment by Rumpl3StiltSkin on Jan 31, 2023 10:20am
Poop, I hear ya. This stock is constantly overlooked cuz it's in Canada, on the Venture X. Yet I think they are just waiting on Clinicians to compile data. I don't think they are waiting until RW is back at the helm, yet that happens middle of next month. I don't think they will miss the Q1 deadline....
Comment by Sunvalley on Jan 31, 2023 10:39am
I dont know about my head , heart or gut but just for the hell of it I might dip my big toe in the water today and buy just a little bit more as the odds seem favourable to the extreme. After all , I,ll still have nine left if things do not go as planned. As I have mentioned in the past , if it is good enough for RDW it ,s good enough for me .You must adnit that he certainly puts his money where ...more  
Comment by tdon1229 on Jan 31, 2023 11:34am
OTOH, I'm not looking forward to having RDW back as CEO ... he's more of a science nerd from the laser side of the house ... he became more of a huckster the last time he held that office as he sought financing (the CFO's job), overstepped, and was censured and banished from leadership roles for five years ... unless he's grown significantly, I don't see him having the ...more  
Comment by Rumpl3StiltSkin on Jan 31, 2023 11:44am
TDon, lol. And I always thought you were RW? Lol. For some reason? Anyway, I think He will only have to navigate as far as the JV/Buyout. I think he has those skills, in spades...
Comment by CancerSlayer on Jan 31, 2023 2:21pm
  A tremendous anmount of value has been created on a shoestring budget, & I have 100% confidence in the science & the clinical data moving forward.  The strong data/drug versatility/reduced risk & attractive pricing will certainly give us some leverage at the negotiation table.  However, it generally takes lots of cash to have an upper hand.  Having the ability ...more  
Comment by CancerSlayer on Jan 31, 2023 2:31pm
  A tremendous amount of value has been created on a shoestring budget, & I have 100% confidence in the science & the clinical data moving forward.  The strong data/drug versatility/reduced risk & attractive pricing will certainly give us some leverage at the negotiation table.  However, it generally takes lots of cash to have an upper hand.  Having the ability to ...more  
Comment by ScienceFirst on Jan 31, 2023 12:27pm
I'd say much better than what big pharmas executives have delivered, in their very specific duties, surrounded by all experts and expertise they want/need, all this, in a very stable environment.  None of them had to build anything from scratch.  None.  Zero. The heavy lifting has been done and the next 2 indications will no more be in unchartered territories on all fronts ...more  
Comment by ScienceFirst on Jan 31, 2023 12:34pm
TLT will put itself on sales after GBM and NSCLC Ph. 1b. It's been clear right before they even started NMIBC Ph. 1b. So far, all this under a shoestring R&D budget and with higher efficacy than any big pharma and biotech has ever been close to deliver over the last 50y. Without the many initiatives of Roger, nothing have happened.
Comment by ScienceFirst on Jan 31, 2023 12:48pm
TLT will put itself on sales after GBM and NSCLC Ph. 1b. It's been clear right before they even started NMIBC Ph. 1b. So far, all this under a shoestring R&D budget and with higher efficacy than any big pharma and biotech has ever been close to deliver over the last 50y. Without the many initiatives of Roger, nothing of all this would have happened.  The molecule of Dr. McFarland ...more  
Comment by N0taP00p on Jan 31, 2023 1:05pm
RDW has got it this far, that's for sure on very little funding. And he's putting his money where his mouth is. It did create some issues with the strictures imposed but hopefully the market sees past that. Maybe it's hard to keep track of all the lines that can't be crossed in smaller companies when you're playing many roles.    People get away with far worse.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250